Les publications HAL U917

2020

38 publication(s):

Note: when necessary, only the first 10 authors are displayed.

Articles

: 2 -
: A new set of reagents and related software used for NGS based classical and non-classical HLA typing showing evidence for a greater HLA haplotype diversity
: M. Alizadeh, C. Picard, C. Frassati, A. Walencik, a Cesbron Gauthier, F. Bennasar, F. Verite, G. Semana, A. Cesbron Gauthier
: Human Immunology, 2020, 81 (5), pp.202-205.
: DOI : https://doi.org/10.1016/j.humimm.2020.02.003
: Pubmed : 32122686

: 3 -
: Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project
: Clément Bailly, Thomas Carlier, Alina Berriolo-Riedinger, Olivier Casasnovas, Emmanuel Gyan, Michel Meignan, Anne Moreau, Barbara Burroni, Loïc Djaileb, Rémy Gressin et al.
: Haematologica, 2020, 104 (1), pp.e33-e36.
: DOI : https://doi.org/10.3324/haematol.2019.223016
: Pubmed : 31371411

: 4 -
: Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response
: Wendy Beguelin, Matt Teater, Cem Meydan, Kenneth B. Hoehn, Jude M. Phillip, Alexey A. Soshnev, Leandro Venturutti, Martin A. Rivas, Maria T. Calvo-Fernandez, Johana Gutierrez et al.
: Cancer Cell, 2020, 37 (5), pp.655-+.
: DOI : https://doi.org/10.1016/j.ccell.2020.04.004
: Pubmed : 32396861

: 5 -
: The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation
: Fabrice Chatonnet, Amandine Pignarre, Aurelien Serandour, Gersende Caron, Stéphane Avner, Nicolas Robert, Alboukadel Kassambara, Audrey Laurent, Maud Bizot, Xabier Agirre et al.
: Haematologica, 2020, 105 (3), pp.774-783.
: DOI : https://doi.org/10.3324/haematol.2019.222133
: Pubmed : 31221779

: 6 -
: Early F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab
: Aiping Chen, Fatima-Zohra Mokrane, Lawrence Schwartz, Franck Morschhauser, Apasia Stamatoullas, Jean-Marc Schiano de Colella, Laetitia Vercellino, Olivier Casasnovas, Adrien Chauchet, Alain Delmer et al.
: Journal of Nuclear Medicine, 2020, 61 (5), pp.649-654.
: DOI : https://doi.org/10.2967/jnumed.119.232827
: Pubmed : 31628220

: 7 -
: High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice
: Laura Couloume, Laetitia Barbin, Emmanuelle Leray, Sandrine Wiertlewski, Emmanuelle Le Page, Anne Kerbrat, Solenn Ory, Damien Le Port, Gilles Edan, David-Axel Laplaud et al.
: Multiple Sclerosis Journal, 2020, 26 (14), pp.1898-1906.
: DOI : https://doi.org/10.1177/1352458519894713
: Pubmed : 31845825

: 8 -
: Activated CD4(+) T Cells impact adipose-serived stromal cell function through CD40-dependant activation
: J.L. Dulong, Séverine Loisel, Léa Verdière, Nadège Bescher, Isabelle Bezier, Monique Peffault de Latour, C. Menard, N. Bertheuil, David Roulois, Karin Tarte et al.
: Cytotherapy, 2020, 22 (5 Supplement), pp.S27-S28.
: DOI : https://doi.org/10.1016/j.jcyt.2020.03.008

: 9 -
: Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
: Hermann Einsele, Javier Briones, Fabio Ciceri, Irene García-Cadenas, Fred Falkenburg, Natacha Bolaños, H M Mirjam Heemskerk, Roch Houot, Michael Hudecek, Franco Locatelli et al.
: HemaSphere, 2020, 4 (4), pp.e423.
: DOI : https://doi.org/10.1097/HS9.0000000000000423
: Pubmed : 32904089

: 10 -
: Management and outcome of primary CNS lymphoma in the modern era
: Caroline Houillier, Carole Soussain, Hervé Ghesquières, Pierre Soubeyran, Olivier Chinot, Luc Taillandier, Thierry Lamy, Sylvain Choquet, Guido Ahle, Gandhi Damaj et al.
: Management and outcome of primary CNS lymphoma in the modern era: An LOC network study. Neurology, 2020, 94 (10), pp.e1027-e1039.
: DOI : https://doi.org/10.1212/WNL.0000000000008900
: Pubmed : 31907289